Skip to main content
Clinical Trials/NCT02699554
NCT02699554
Completed
Not Applicable

Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy

University of Washington1 site in 1 country55 target enrollmentSeptember 2015
ConditionsCerebral Palsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
University of Washington
Enrollment
55
Locations
1
Primary Endpoint
Change in Walk Dynamic Motor Control Index 6-months After Orthopaedic Surgery
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Impaired neuromuscular control hinders movement for individuals with cerebral palsy and other neurological disorders. In this research, the investigators are developing new tools to quantify impaired neuromuscular control in cerebral palsy and evaluate changes after one of the most common treatments, orthopaedic surgery. The results from this research will empower clinicians to identify patient-specific factors that contribute to impaired movement and improve treatment and quality of life.

Detailed Description

The long-term goals of this research are to quantify patient-specific changes in neuromuscular control in order to optimize treatment planning and improve mobility for individuals with cerebral palsy (CP). As a first step, the aims of this proposal are to evaluate neuromuscular control before and after one of the most common treatments for individuals with CP, orthopaedic surgery. The investigators will evaluate if patient-specific measures of neuromuscular control, based upon the framework of muscle synergies, can predict improvements in walking ability after surgery. Further, investigators will determine whether neuromuscular control changes after surgery and if these changes contribute to improvements in movement. To achieve these goal the investigators will implement and test new tools to quantify neuromuscular control which integrate clinical gait analysis and two computational techniques: synergy analysis and dynamic musculoskeletal simulation. This research will provide the foundation to use measures of altered neuromuscular control to inform treatment planning, develop alternative treatments, and improve mobility in CP and other neurologic disorders.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
September 2020
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Katherine Steele

Assistant Professor, Mechanical Engineering

University of Washington

Eligibility Criteria

Inclusion Criteria

  • Diplegic cerebral palsy
  • Mild or Moderate Impairment, Gross Motor Function Classification System (GMFCS) Levels I-III
  • Will receive follow-up care and physical therapy within the Gillette Children's Specialty Healthcare system

Exclusion Criteria

  • Botulinum toxin injections, baclofen, or other similar treatments in the 3 months prior to pre-operative gait analysis

Outcomes

Primary Outcomes

Change in Walk Dynamic Motor Control Index 6-months After Orthopaedic Surgery

Time Frame: 6-months after individual's orthopaedic surgery

The Walk Dynamic Motor Control Index (Walk DMC) is a specific measurement calculated from electromyography during gait using nonnegative matrix factorization. A value of 100 indicates complexity of neuromuscular control similar to typically-developing peers and each 10 point deviation represents one standard deviation from typically-developing peers. Thus, a value of 80 would indicate that an individual's muscle coordination during gait is two standard deviations below the complexity of unimpaired individuals.

Change in Walk Dynamic Motor Control Index 1-year After Orthopaedic Surgery

Time Frame: 1-year after individual's orthopaedic surgery

The Walk Dynamic Motor Control Index (Walk DMC) is a specific measurement calculated from electromyography during gait using nonnegative matrix factorization. A value of 100 indicates complexity of neuromuscular control similar to typically-developing peers and each 10 point deviation represents one standard deviation from typically-developing peers. Thus, a value of 80 would indicate that an individual's muscle coordination during gait is two standard deviations below the complexity of unimpaired individuals.

Secondary Outcomes

  • Change in Gait Deviation Index 6-months After Orthopaedic Surgery(6-months after individual's orthopaedic surgery)
  • Change in Gait Deviation Index 1-year After Orthopaedic Surgery(1-year after individual's orthopaedic surgery)

Study Sites (1)

Loading locations...

Similar Trials